<DOC>
	<DOC>NCT01287806</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and effect of ulinastatin in inhalation lung injury patients.</brief_summary>
	<brief_title>Ulinastatin in Inhalation Lung Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Urinastatin</mesh_term>
	<criteria>Moderate to severe inhalation lung injury Within 48hours after inhalation injury Age 18 to 70 years old Burned area not more than 70% TBSA Signed the informed consent form Pregnancy or lactation Allergy for ulinastatin Received an investigational drug or device within 90 days prior to entering study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>ulinastatin</keyword>
	<keyword>inhalation injury</keyword>
</DOC>